Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Cancer
|
November 15, 1989
Evaluation of serum levels of soluble interleukin-2 receptor in patients with chronic lymphoproliferative disorders of T-lymphocytes
R Zambello, G Pizzolo, L Trentin, et al.
Leukemia
|
November 1, 1991
Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes
R Zambello, M A Cassatella, L Trentin, et al.
Cancer
|
December 15, 1987
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions
G Semenzato, F Pandolfi, T Chisesi, et al.
Journal of Clinical & Laboratory Immunology
|
July 1, 1986
The analysis of expanded cells from patients with lymphoproliferative disorders of granular lymphocytes may help to clarify the NK cell differentiation
R Zambello, T Chisesi, G De Rossi, et al.
Leukemia & Lymphoma
|
July 28, 2016
Treatment of Early Stage Hodgkin's Disease According to Risk Factors
T Chisesi, M Vespignani, G Capnist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1994
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group
M R Sertoli, G Santini, T Chisesi, et al.
Haematologica
|
December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study
R Bassan, E Pogliani, T Lerede, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups
R Bassan, E Pogliani, P Casula, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group
G Santini, L Salvagno, P Leoni, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Cancer
|
November 15, 1989
Evaluation of serum levels of soluble interleukin-2 receptor in patients with chronic lymphoproliferative disorders of T-lymphocytes
R Zambello, G Pizzolo, L Trentin, et al.
Leukemia
|
November 1, 1991
Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes
R Zambello, M A Cassatella, L Trentin, et al.
Cancer
|
December 15, 1987
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions
G Semenzato, F Pandolfi, T Chisesi, et al.
Journal of Clinical & Laboratory Immunology
|
July 1, 1986
The analysis of expanded cells from patients with lymphoproliferative disorders of granular lymphocytes may help to clarify the NK cell differentiation
R Zambello, T Chisesi, G De Rossi, et al.
Leukemia & Lymphoma
|
July 28, 2016
Treatment of Early Stage Hodgkin's Disease According to Risk Factors
T Chisesi, M Vespignani, G Capnist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1994
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group
M R Sertoli, G Santini, T Chisesi, et al.
Haematologica
|
December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study
R Bassan, E Pogliani, T Lerede, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups
R Bassan, E Pogliani, P Casula, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group
G Santini, L Salvagno, P Leoni, et al.
Page
of 2